Patents by Inventor Patrick SHILLING

Patrick SHILLING has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Synthetically evolved DNA constructs for regulating signal peptide performance as well as vectors, host cells and recombinant proteins thereof
    Patent number: 12570987
    Abstract: The present invention provides a simple and inexpensive system for regulating signal peptide performance by using a synthetically evolved nucleotide sequence. The invention further relates to an expression vector comprising the nucleotide sequence. Additionally, the present invention relates to host cell comprising the expression vector. Furthermore, the present invention relates to a recombinant protein expressed by the host cell as well as a method for expressing the recombinant protein.
    Type: Grant
    Filed: February 5, 2021
    Date of Patent: March 10, 2026
    Assignee: CLONEOPT AB
    Inventors: Kiavash Mirzadeh, Daniel Daley, Patrick Shilling
  • SYNTHETICALLY EVOLVED DNA CONSTRUCTS FOR REGULATING SIGNAL PEPTIDE PERFORMANCE AS WELL AS VECTORS, HOST CELLS AND RECOMBINANT PROTEINS THEREOF
    Publication number: 20240301432
    Abstract: The present invention provides a simple and inexpensive system for regulating signal peptide performance by using a synthetically evolved nucleotide sequence. The invention further relates to an expression vector comprising the nucleotide sequence. Additionally, the present invention relates to host cell comprising the expression vector. Furthermore, the present invention relates to a recombinant protein expressed by the host cell as well as a method for expressing the recombinant protein.
    Type: Application
    Filed: February 5, 2021
    Publication date: September 12, 2024
    Applicants: XBRANE BIOPHARMA AB, CLONEOPT AB
    Inventors: Kiavash MIRZADEH, Daniel DALEY, Patrick SHILLING